We are live on ! Find out more
TCM

Towercrest Capital Management Portfolio holdings

AUM $642M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
+4.18%
1 Year Est. Return
+11.71%
3 Year Est. Return
+31.42%
5 Year Est. Return
+23.73%
10 Year Est. Return
+78.8%
AUM
$391M
AUM Growth
+$30.9M
Cap. Flow
-$15.9M
Cap. Flow %
-4.05%
Top 10 Hldgs %
49.69%
Holding
81
New
11
Increased
48
Reduced
11
Closed
2

Sector Composition

Rank Sector Weight
1 Financials 3.32%
2 Technology 1.45%
3 Communication Services 0.88%
4 Healthcare 0.62%
5 Consumer Staples 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGGY icon
76
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$922M
$212K 0.05%
4,050
PEG icon
77
Public Service Enterprise Group
PEG
$38.6B
$212K 0.05%
+3,589
New +$218K
VTI icon
78
Vanguard Morningstar Total Stock Market ETF
VTI
$657B
$210K 0.05%
+1,283
New +$201K
VGT icon
79
Vanguard Information Technology ETF
VGT
$139B
$206K 0.05%
+6,720
New +$192K
ADPT icon
80
Adaptive Biotechnologies
ADPT
$3.87B
-11,000
Closed -$340K
IBM icon
81
IBM
IBM
$209B
-1,492
Closed -$207K

Similar funds

Towercrest Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Towercrest Capital Management held 81 positions worth $391M, up 8.6% from $361M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Towercrest Capital Management withdrew a net $15.9M in Q4 2019, closing 2 positions and reducing 11 holdings. Its most notable exit was Adaptive Biotechnologies, an estimated $340K position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.3% of assets, down from 3.7% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Towercrest Capital Management opened a new position in Vanguard Real Estate ETF worth $1.64M.

  • Towercrest Capital Management's largest Q4 2019 buy was Vanguard Real Estate ETF: 17,704 shares worth $1.64M.
  • Towercrest Capital Management added most to iShares Core S&P 500 ETF in Q4 2019, an estimated $1.14M increase.
  • Towercrest Capital Management's biggest Q4 2019 reduction was Berkshire Hathaway Class A, cutting an estimated $32.6M.
  • Towercrest Capital Management fully exited Adaptive Biotechnologies in Q4 2019, selling an estimated $340K.
  • Towercrest Capital Management's ten largest holdings make up 50% of its $391M portfolio in Q4 2019.
  • Towercrest Capital Management opened 11 new positions and closed 2 in Q4 2019.
  • Towercrest Capital Management's portfolio value rose 8.6% quarter-over-quarter to $391M.

Based on Towercrest Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.